|Number of samples:||4|
|Release date:||Sep 8 2018|
|Last update date:||Nov 30 2018|
|Diseases:||Congenital Abnormalities, Carcinoma, Renal Cell, Melanoma, Neoplasms|
|Dataset link||Defective transcription elongation in a subset of cancers confers immunotherapy resistance (B16 ChIP-Seq)|
RNA pol2 chipseq was perforemed on B16-F10 control and flavopiridol(25nM for 1 week) treated cell lines to access the impact of chronic inhibition of RNA pol2 elongation inhibition in its genome wide distribution.